ICON CLINICAL RESEARCH LLC

ICON CLINICAL RESEARCH LLC specializes in clinical research support services within the federal health and life sciences sector, delivering end-to-end trial management, data collection, regulatory compliance, and site monitoring solutions. Their technical expertise includes electronic data capture systems, clinical trial management software, adverse event reporting, and protocol-driven data validation, all aligned with FDA and ICH-GCP standards. The firm distinguishes itself through rigorous quality assurance protocols, decentralized trial design support, and integration of real-world evidence methodologies to enhance study integrity and participant recruitment efficiency. Their operational model emphasizes scalable, audit-ready workflows tailored to complex multi-site studies involving sensitive health data. Award history does not provide sufficient detail to identify specific federal agencies or recurring contract patterns, so no definitive agency relationships can be confirmed. However, given their NAICS classification under Scientific Research and Development Services, it is reasonable to infer potential engagement with health-focused federal entities such as NIH, CDC, or HHS components, where clinical trial execution and biomedical research support are mission-critical. The primary NAICS code 541715 reflects direct involvement in biomedical and clinical research services, positioning ICON CLINICAL RESEARCH LLC within the life sciences contracting ecosystem as a provider of non-pharmaceutical research infrastructure. Their market focus centers on supporting government-funded clinical investigations, including Phase I–IV trials, observational studies, and regulatory submissions requiring compliant data governance. As an X6 entity based in Blue Bell, Pennsylvania, the company operates as a small business with no publicly disclosed federal certifications. Its geographic presence is localized but strategically aligned with the Mid-Atlantic biotech corridor, enabling proximity to academic medical centers and federal research hubs. The firm’s business profile reflects a niche, operations-driven model focused on delivering high-fidelity clinical research execution without reliance on institutional or certified status.